Siirry sisältöön

Perioperatiivinen hoito

Hemostaasin ylläpito ja optimointi

Antifibrinolyytit

Alternatives to allogeneic platelet transfusion. (avaa uuden ikkunan)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Lähde‎: Br J Haematol 2016;175(3):381-92.

Arkistoitu‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (avaa uuden ikkunan)

Tranexamic acid in patients undergoing noncardiac surgery. (avaa uuden ikkunan)

Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, Chan MTV, Borges FK, Martínez-Zapata MJ, Wang CY, Xavier D, Ofori SN, Wang MK, Efremov S, Landoni G, Kleinlugtenbelt YV, Szczeklik W, Schmartz D, Garg AX, Short TG, Wittmann M, Meyhoff CS, Amir M, Torres D, Patel A, Duceppe E, Ruetzler K, Parlow JL, Tandon V, Fleischmann E, Polanczyk CA, Lamy A, Astrakov SV, Rao M, Wu WKK, Bhatt K, de Nadal M, Likhvantsev VV, Paniagua P, Aguado HJ, Whitlock RP, McGillion MH, Prystajecky M, Vincent J, Eikelboom J, Copland I, Balasubramanian K, Turan A, Bangdiwala SI, Stillo D, Gross PL, Cafaro T, Alfonsi P, Roshanov PS, Belley-Côté EP, Spence J, Richards T, VanHelder T, McIntyre W, Guyatt G, Yusuf S, Leslie K; POISE-3 Investigators

Lähde‎: N Engl J Med. 2022;386(21):1986-97.

Arkistoitu‎: PubMed 35363452

DOI‎: 10.1056/NEJMoa2201171

https://pubmed.ncbi.nlm.nih.gov/35363452/ (avaa uuden ikkunan)

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. (avaa uuden ikkunan)

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K.

Lähde‎: Cochrane Database Syst Rev 2011;(3):CD001886.

Arkistoitu‎: PubMed 21412876

DOI‎: 10.1002/14651858.CD001886.pub4

https://www.ncbi.nlm.nih.gov/pubmed/21412876 (avaa uuden ikkunan)

Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. (avaa uuden ikkunan)

Howell N, Senanayake E, Freemantle N, Pagano D.

Lähde‎: J Thorac Cardiovasc Surg 2013;145(1):234-40.

Arkistoitu‎: PubMed 22889481

DOI‎: 10.1016/j.jtcvs.2012.07.018

https://www.ncbi.nlm.nih.gov/pubmed/22889481 (avaa uuden ikkunan)

Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. (avaa uuden ikkunan)

Taeuber I, Weibel S, Herrmann E, Neef V, Schlesinger T, Kranke P, Messroghli L, Zacharowski K, Choorapoikayil S, Meybohm P

Lähde‎: JAMA Surg 2021;156(6):e210884.

Arkistoitu‎: PubMed 33851983

DOI‎: 10.1001/jamasurg.2021.0884

https://www.ncbi.nlm.nih.gov/pubmed/33851983 (avaa uuden ikkunan)

Oral is as effective as intravenous tranexamic acid at reducing blood loss in thoracolumbar spinal fusions: a prospective randomized trial. (avaa uuden ikkunan)

Yu CC, Fidai M, Washington T, Bartol S, Graziano G

Lähde‎: Spine 2022;47(2):91-8.

Arkistoitu‎: PubMed 34224510

DOI‎: 10.1097/BRS.0000000000004157

https://pubmed.ncbi.nlm.nih.gov/34224510/ (avaa uuden ikkunan)

Aktivoitu rekombinantti hyytymistekijä VII (rFVIIa)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (avaa uuden ikkunan)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Lähde‎: Transfusion 2009;49 Suppl 5:240S-7S.

Arkistoitu‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (avaa uuden ikkunan)

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (avaa uuden ikkunan)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Lähde‎: Circulation 2008;118(4):331-8.

Arkistoitu‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 (avaa uuden ikkunan)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (avaa uuden ikkunan)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Lähde‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Arkistoitu‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (avaa uuden ikkunan)

Hyytymistekijätiivisteet

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (avaa uuden ikkunan)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Lähde‎: Ann Thorac Surg 2009;88(5):1666-8.

Arkistoitu‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 (avaa uuden ikkunan)

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (avaa uuden ikkunan)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Lähde‎: A A Case Rep 2015;4(10):140-2.

Arkistoitu‎: PubMed 25974419

DOI‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 (avaa uuden ikkunan)

Fibrinogen replacement therapy: a critical review of the literature. (avaa uuden ikkunan)

Franchini M, Lippi G.

Lähde‎: Blood Transfus 2012;10(1):23-7.

Arkistoitu‎: PubMed 22153684

DOI‎: 10.2450/2011.0015-11

https://www.ncbi.nlm.nih.gov/pubmed/22153684 (avaa uuden ikkunan)

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (avaa uuden ikkunan)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Lähde‎: Thromb Haemost 2009;102(1):137-44.

Arkistoitu‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 (avaa uuden ikkunan)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (avaa uuden ikkunan)

Levy JH, Welsby I, Goodnough LT.

Lähde‎: Transfusion 2014;54(5):1389-405.

Arkistoitu‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (avaa uuden ikkunan)

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (avaa uuden ikkunan)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Lähde‎: Anesthesiology 2013;118(1):40-50.

Arkistoitu‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 (avaa uuden ikkunan)

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. (avaa uuden ikkunan)

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Lähde‎: Can J Anaesth 2012;59(3):299-303.

Arkistoitu‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 (avaa uuden ikkunan)

Desmopressiini

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. (avaa uuden ikkunan)

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Lähde‎: Anaesthesia 2010;65(7):688-91.

Arkistoitu‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 (avaa uuden ikkunan)

Viskoelastiset testit kirurgisen vuodon tai koagulopatian tunnistamiseksi

Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. (avaa uuden ikkunan)

Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, Fries D, Görlinger K, Haas T, Imberger G, Jacob M, Lancé M, Llau J, Mallett S, Meier J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelsø AJ, Wouters P, Wyffels P.

Lähde‎: Eur J Anaesthesiol 2013;30(6):270-382.

Arkistoitu‎: PubMed 23656742

DOI‎: 10.1097/EJA.0b013e32835f4d5b

https://www.ncbi.nlm.nih.gov/pubmed/23656742 (avaa uuden ikkunan)